CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients

CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients

In gastric cancer (GC), biomarkers that define prognosis and predict treatment response remain scarce. We hypothesized that the extent of CD44v6 membranous tumor expression could predict prognosis and therapy response in GC patients. Two GC surgical cohorts, from Portugal and South Korea (<i>n...

Full description

Bibliographic Details
Main Authors: Gabriela M Almeida, Carla Pereira, Ji-Hyeon Park, Carolina Lemos, Sofia Campelos, Irene Gullo, Diana Martins, Gilza Gonçalves, Dina Leitão, João Luís Neto, Ana André, Clara Borges, Daniela Almeida, Hyuk-Joon Lee, Seong-Ho Kong, Woo Ho Kim, Fátima Carneiro, Raquel Almeida, Han-Kwang Yang, Carla Oliveira
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Biomedicines
Subjects:
stomach neoplasms
genetic heterogeneity
biomarkers
drug therapy
conventional chemotherapy
gastric surgery
Online Access:https://www.mdpi.com/2227-9059/9/9/1249

Similar Items

Similar Items